The potential of next-generation microbiological diagnostics to improve bioterrorism detection speed

Risk Analysis

Volumn 24, Issue 3, 2004, Pages 521-536

  Casman, Elizabeth A ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Bioterrorism surveillance; Disease; Dual use; Early detection; Zebra chip

Indexed keywords

MEDICAL APPLICATIONS; MICROBIOLOGY; PATIENT MONITORING; PROBABILITY;

BIOTERRORISM; MICROBIOLOGICAL DIAGNOSTICS;

RISK MANAGEMENT;

BIOLOGICAL WEAPON; DETECTION METHOD; MICROBIOLOGY; TERRORISM;

BIOLOGICAL WARFARE; DEVICE; FLU LIKE SYNDROME; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MASS SCREENING; MICROBIOLOGICAL EXAMINATION; REVIEW;

BIOTERRORISM; HUMANS; MICROBIOLOGICAL TECHNIQUES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POPULATION SURVEILLANCE; PROBABILITY; RISK; TIME FACTORS; UNITED STATES;

EID: 3042798276     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0272-4332.2004.00456.x     Document Type: Review

References (70)

1. Kaufmann, A., Meltzer, M., & Schmid, G. (1997). The economic impact of a bioterrorist attack: Are prevention and postattack intervention programs justifiable? Emerging Infectious Diseases, 3, 83-94.
2. Wagner, M. M., Tsui, F. C., Espino, J. U., Dato, V. M., Sittig, D. F., Caruana, R. A., McGinnis, L. F., Deerfield, D. W., Druzdzel, M. J., & Fridsma, D. B. (2001). The emerging science of very early detection of disease outbreaks. Journal of Public Health Management and Practice, 7, 51-59.
3. Young, D. (2001). First Alert: LEADERS, a Medical Surveillance System, Gives Health Officials a Powerful New Weapon in the Fight Against Infections Diseases. Government Computer News. Available at http://www.gcn.com/state/vol7- no5/tech-report/1027-1.html, last accessed August 21, 2002.
4. Brocato, C. E., & Miller, G. T. (2002). The next agent of terror? Understanding smallpox and its implications for prehospital crews. Journal of Emergency Medical Services: JEMS, 27, 44-50, 52-45.
5. Lazarus, R., Kleinman, K., Dashevsky, I., Adams, C., Kludt, P., DeMaria, A. Jr., & Platt, R. (2002). Use of automated ambulatory-care encounter records for detection of acute illness clusters, including potential bioterrorism events. Emerging Infectious Diseases, 8, 753-760.
6. Lober, W. B., Karras, B. T., Wagner, M. M., Overhage, J. M., Davidson, A. J., Fraser, H., Trigg, L. J., Mandl, K. D., Espino, J. U., & Tsui, F. C. (2002). Roundtable on bioterrorism detection: Information system-based surveillance. Journal of the American Medical Informatics Association, 9, 105-115.
7. Sandia National Laboratory. (2001). Sandia National Laboratory SNL's Rapid Syndromic Validation Project (RSVP). Available at http://www.cmc.sandia. gov/bio/rsvp/index.html, last accessed August 20, 2002.
8. Teich, J. M., Wagner, M. M., Mackenzie, C. F., & Schafer, K. O. (2002). The informatics response in disaster, terrorism, and war. Journal of the American Medical Informatics Association, 9, 97-104.
9. Goldenberg, A., Shmueli, G., Caruana, R. A., & Fienberg, S. E. (2002). Early statistical detection of anthrax outbreaks by tracking over-the-counter medication sales. Proceedings of the National Academy of Science of the United States of America, 99, 5237-5240.
10. Poste, G. (2001). Advances in biotechnology: Promise and peril. Presented at the Second National Symposium on Medical and Public Health Response to Bioterrorism. Washington, DC, November 28-29, 2000. The Johns Hopkins University Center for Civilian Biodefense Strategies. Available at http://www.hopkins- biodefense.org/sympcast/transcripts/trans_post.html, last accessed August 19, 2002.
11. Institute of Medicine. (1999). Chemical and Biological Terrorism: Research and Development to Improve Civilian Medical Response. Washington, DC: National Academy Press.
12. Enserink, M. (2001). ANTHRAX: Biodefense hampered by inadequate tests. Science, 294, 1266-1267.
13. Specter, S., Hodinka, R. L., & Young, S. A. (2000). Clinical Virology Manual. Washington, DC: American Society for Microbiology Press.
14. Inglesby, T., Henderson, D., Bartlett, J., Ascher, M., Eitzen, E., Friedlander, A., Hauer, J., McDade, J., Osterholm, M., O'Toole, T., Parker, G., Perl, T., Russell, P., & Tonat, K. (1999). Smallpox as a biological weapon: Medical and public health management. Working group on civilian biodefense. Journal of the American Medical Association, 281, 1735-1745.
15. Haines, J. D., Pitts, P. A.-C., & Crutcher, J. M. (2000). Medical response to bioterrorism: Are we prepared? Journal of the Oklahoma State Medical Association, 93, 187-196.
16. Bartlett, J. G. (1999). Applying lessons learned from anthrax case history to other scenarios. Emerging Infectious Diseases, 5, 561-563.
17. O'Toole, T. (1999). Smallpox: An attack scenario. Emerging Infectious Disease, 5, 540-546.
18. Jernigan, J. A., Stephens, D. S., Ashford, D. A., Omenaca, C., Topiel, M. S., Galbraith, M., Tapper, M., Fisk, T. L., Zaki, S., Popovic, T., Meyer, R. F., Quinn, C. P., Harper, S. A., Fridkin, S. K., Sejvar, J. J., Shepard, C. W.; McConnell, M., Guarner, J., Shieh, W. J., Malecki, J. M., Gerberding, J. L., Hughes, J. M., & Perkins, B. A. (2001). Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerging Infectious Disease, 7, 933-944.
19. O'Toole, T. (2001). Congressional Testimony: Terrorism Through the Mail: Protecting Postal Workers and the Public (Part II), Center for Civilian Biodefense Strategies. The Johns Hopkins University. Available at http://www.hopkins-biodefense.org/pages/library/otoole.htm, last accessed August 19, 2002.
20. Anthony, J. G., Linske-O'Connell, L., & Lörincz, A. T. (2000). Nucleic acid hybridization. In S. Specter, R. L. Hodinka, & S. A. Young (Eds.), Clinical Virology Manual, 3rd ed. (p. 169). Washington, DC: American Society for Microbiology Press.
21. Kothapalli, R., Yoder, S. J., Mane, S., & Loughran, T. P. Jr. (2002). Microarray results: How accurate are they? BMC Bioinformatics, 3, 22.
22. Marshall, A., & Hodgson, J. (1998). DNA chips: An array of possibilities. Nature Biotechnology, 16, 2731.
23. Rupert. F. (2000). Genomics and proteomics tools for the clinic. Current Opinion in Molecular Therapeutics, 2, 633-642.
24. Wang, J. (2000). Survey and summary: From DNA biosensors to gene chips. Nucleic Acids Research, 28, 3011-3016.
25. McGlennen, R. C. (2001). Miniaturization technologies for molecular diagnostics. Clinical Chemistry, 47, 393-402.
26. SRI International. (1999). Available at http://www.sri.com/structure/ chembio.html, last accessed April 30, 2001.
27. Cepheid Inc. (2000). Cepheid Ships Portable DNA Analyzers to U.S. Department of Defense and Centers for Disease Control. Available at http://www.cepheid.com/gages/press.htm, last accessed April 3, 2001.
28. IDI. (2000). IDI's Family- and Genus-Specific Assays. Available at http://www.infectio.com/en/recherche/patho.html, last accessed April 30, 2001.
29. White, D. C., Lytle, C. A., Gan, Y. D., Piceno, Y. M., Wimpee, M. H., Peacock, A. D., & Smith, C. A. (2002). Flash detection/identification of pathogens, bacterial spores and bioterrorism agent biomarkers from clinical and environmental matrices. Journal of Microbiological Methods, 48, 139-147.
30. MIDI Inc. (2002). Bacterial Identification by Cellular Fatty Acid Analysis. Available at http://www.midi-inc.com/, last accessed December 5, 2002.
31. Henderson, D. A., Inglesby, T. V., Bartlett, J. G., Ascher, M. S., Eitzen, E., Jahrling, P. B., Hauer, J., Layton, M., McDade, J., Osterholm, M. T., O'Toole, T., Parker, G., Perl, T. M., Russell, P. K., & Tonat, K. (1999). Smallpox as a biological weapon: Medical and public health management. Journal of the American Medical Association, 281, 2127-2137.
32. Mitra, A. C., Chatterjee, S. N., Sarkar, J. K., Manji, P., & Das, A. K. (1966). Viraemia in haemorrhagic and other forms of smallpox. Journal of the Indian Medical Association, 47, 112-114.
33. Brookmeyer, R., & Blades, N. (2002). Prevention of inhalational anthrax in the U.S. outbreak. Science, 295, 1861.
34. Friedlander, A. M. (1997). Anthrax. In F. R. Sidell, E. T Takafuji, & D. R. Franz (Eds.), Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of the Surgeon General at TMM Publications.
35. Dixon, T. C., Meselson, M., Guillemin, J., & Hanna, P. C. (1999). Anthrax. New England Journal of Medicine, 341, 815-826.
36. Fenner, F., Henderson, D. A., Arita, I., Ježek, Z. & Ladnyi, I. D. (1988). Smallpox and its Eradication. Geneva: World Health Organization.
37. Cieslak, T. J., & Eitzen, E. M. Jr. (1999). Clinical and epidemiologic principles of anthrax. Emerging Infectious Diseases, 5, 552-555.
38. Inglesby, T. V. (1999). Anthrax, A possible case history. Emerging Infectious Diseases, 5, 556-560.
39. Meltzer, M. I., Damon, I., LeDuc, J. W., & Millar, J. D. (2001). Modeling potential responses to smallpox as a bioterrorist weapon. Emerging Infectious Disease, 7, 959-969.
40. Kaplan, E. H., Craft, D. L., & Wein, L. M. (2002). Emergency response to a smallpox attack: The case for mass vaccination. Proceedings of the National Academy of Science USA, 99, 10935-10940.
41. O'Toole, T., Mair, M., & Inglesby, T. V. (2002). Shining light on "Dark Winter." Clinical Infectious Disease, 34, 972-983.
42. U.S. Department of the Census. (2000). Population Projections of the Total Resident Population by Quarter: Middle Series, April 1, 1999 to January 1, 2101. Available at http://www. census.gov/population/www/projections/natsum-T1. html, last accessed July 25, 2002.
43. Centers for Disease Control and Prevention, National Center for Health Statistics. (2001). Health United States, 2001 with Urban and Rural Health Chartbook. Hyattsville, MD.
44. Stussman, B. J. (1997). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
45. McCaig, L. F., & Stussman, B. J. (1997). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
46. Nourjah, P. (1999). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
47. McCaig, L. F. (2000). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
48. McCaig, L. F., & Burt, C. W. (2001). Advance Datafrom Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
49. McCaig, L. F., & Ly, N. (2002). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
50. Woodwell, D. A. (1997). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
51. Woodwell, D. A. (1997). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
52. Department of Health and Human Services, Agency for Healthcare Research and Quality. (1999). MEPSnet Analytical Tools. Available at http://www.meps. ahrq.gov/mepsnet/MEPSnetintro.htm and http:///www.meps.ahrq.gov/data_ public.htm, last accessed July 25, 2002.
53. Woodwell, D. A. (1999). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
54. Woodwell, D. A. (2000). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
55. Cherry, D. K., Burt, C. W., & Woodwell, D. A. (2001). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
56. Cherry, D. K., & Woodwell, D. A. (2002). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
57. McCaig, L. F. (1997). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
58. McCaig, L. F. (1997). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
59. McCaig, L. F. (1999). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
60. Slusarcick, A. L., & McCaig, L. F. (2000). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
61. Nghi, L., McCaig, L. F., & Burt, C. W. (2001). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
62. Nghi, L., & McCaig, L. F. (2002). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
63. Graves, E. J., & Owings, M. F. (1997). 1995 Summary: National Hospital Discharge Survey. Advance Data, 291, Sept. 4. Available at www.cdc.gov/nchs/data/ad/ad291.pdf.
64. Graves, E. J., & Owings, M. F. (1998). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
65. Lawrence, L., & Hall, M. J. (1999). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
66. Hall, M. J., & Popovic, J. R. (2000). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
67. Popovic, J. R., & Hall, M. J. (2001). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
68. Hall, M. J., & Owings, M. F. (2002). Advance Data from Vital and Health Statistics. Hyattsville, MD: National Center for Health Statistics.
69. Veterans Administration. (2002). Veteran Data and Information: Program Statistics, FY 2001 Annual Accountability Report Statistical Appendix. Available at http://www.va. gov/vetdata/ProgramStatics/index.htm, last accessed June 6, 2002.
70. National Blood Data Resource Center. (2002). FAQs. Available at http://www.nbdrc.org/faqs.htm, last accessed May 2, 2002.